X-ray structure of antistasin at 1.9 Å resolution and its modelled complex with blood coagulation factor Xa

The three‐dimensional structure of antistasin, a potent inhibitor of blood coagulation factor Xa, from the Mexican leech Haementeria officinalis was determined at 1.9 Å resolution by X‐ray crystallography. The structure reveals a novel protein fold composed of two homologous domains, each resembling...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The EMBO journal 1997-09, Vol.16 (17), p.5151-5161
Hauptverfasser: Lapatto, Risto, Krengel, Ute, Schreuder, Herman A., Arkema, Anita, de Boer, Bijtske, Kalk, Kor H., Hol, Wim G.J., Grootenhuis, Peter D.J., Mulders, John W.M., Dijkema, Rein, Theunissen, Henri J.M., Dijkstra, Bauke W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The three‐dimensional structure of antistasin, a potent inhibitor of blood coagulation factor Xa, from the Mexican leech Haementeria officinalis was determined at 1.9 Å resolution by X‐ray crystallography. The structure reveals a novel protein fold composed of two homologous domains, each resembling the structure of hirustasin, a related 55‐residue protease inhibitor. However, hirustasin has a different overall shape than the individual antistasin domains, it contains four rather than two β‐strands, and does not inhibit factor Xa. The two antistasin domains can be subdivided into two similarly sized subdomains with different relative orientations. Consequently, the domain shapes are different, the N‐terminal domain being wedge‐shaped and the C‐terminal domain flat. Docking studies suggest that differences in domain shape enable the N‐terminal, but not C‐terminal, domain of antistasin to bind and inhibit factor Xa, even though both have a very similar reactive site. Furthermore, a putative exosite binding region could be defined in the N‐terminal domain of antistasin, comprising residues 15‐17, which is likely to interact with a cluster of positively charged residues on the factor Xa surface (Arg222/Lys223/Lys224). This exosite binding region explains the specificity and inhibitory potency of antistasin towards factor Xa. In the C‐terminal domain of antistasin, these exosite interactions are prevented due to the different overall shape of this domain.
ISSN:0261-4189
1460-2075
DOI:10.1093/emboj/16.17.5151